Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Unicycive Therapeutics, Inc. (UNCY)

3.7400 -0.0700 (-1.84%)
At close: October 30 at 4:00:00 PM EDT
3.2000 -0.5400 (-14.44%)
After hours: October 30 at 7:59:39 PM EDT
Trade UNCY on Coinbase

Financials

Updated yesterday
Powered by Yahoo Scout

Unicycive Therapeutics Incshows a mixed operating picture. Revenue growthstayed flat at 0.00%in FY 2026 Q2, FY 2026 Q1, and FY 2025 Q4, while EPS growthrebounded to 37.02%in FY 2026 Q2after -21.01%in FY 2026 Q1. EBITDA growthremained negative at -12.46%in FY 2026 Q2, though that was less severe than -148.40%in FY 2026 Q1. Cash generation also stayed pressured, with free cash flow yieldimproving from -0.31in FY 2025 Q4to -0.17in FY 2026 Q2, but still negative.

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
104.18M 128.47M 166.06M 124.01M 77.01M 60.90M
Enterprise Value
43.49M 74.83M 124.99M 81.82M 55.15M 41.83M
Trailing P/E
-- -- -- -- -- --
Forward P/E
2.07 -- 3.44 1.71 1.18 --
PEG Ratio (current)
-- -- -- -- -- --
Price/Sales
-- -- -- -- -- --
Price/Book
1.96 -- -- -- -- --
Enterprise Value/Revenue
-- -- -- -- -- --
Enterprise Value/EBITDA
-- -- -- -- -- --
6/30/2025 - 7/12/2021

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends --
Most Recent Quarter (mrq) --

Profitability

Profit Margin --
Operating Margin (ttm) --

Management Effectiveness

Return on Assets (ttm) --
Return on Equity (ttm) --

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) --
Total Cash Per Share (mrq) --
Total Debt (mrq) --
Total Debt/Equity (mrq) --
Current Ratio (mrq) --
Book Value Per Share (mrq) --

Cash Flow Statement

Operating Cash Flow (ttm) --
Levered Free Cash Flow (ttm) --

Trading Information

Stock Price History

Beta (5Y Monthly) --
52 Week Change 3 --
S&P 500 52-Week Change 3 --
52 Week High 3 --
52 Week Low 3 --
50-Day Moving Average 3 --
200-Day Moving Average 3 --

Share Statistics

Avg Vol (3 month) 3 --
Avg Vol (10 day) 3 --
Shares Outstanding 5 --
Implied Shares Outstanding 6 --
Float 8 --
% Held by Insiders 1 --
% Held by Institutions 1 --
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 --
Trailing Annual Dividend Yield 3 --
5 Year Average Dividend Yield 4 --
Payout Ratio 4 --
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: